Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(22 sites)
United States
Clinical Study Center, Dothan, Alabama Clinical Study Center, Pomona, California Clinical Study Center, Boca Raton, Florida Clinical Study Center, Jacksonville, Florida Clinical Study Center, Winter Park, Florida Clinical Study Center, High Point, North Carolina Clinical Study Center, DeSoto, Texas Clinical Study Center, Renton, Washington Australia
Clinical Study Center, Adelaide Clinical Study Center, Melbourne Clinical Study Center, Sydney Canada
Clinical Study Center, Chicoutimi Clinical Study Center, Montreal Clinical Study Center, Toronto Clinical Study Center, Vancouver Israel
Clinical Study Center, Rehovot New Zealand
Clinical Study Center, Christchurch United Kingdom
Clinical Study Center, Birmingham Clinical Study Center, Edinburgh Clinical Study Center, London Clinical Study Center, Manchester Clinical Study Center, Nottingham